Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donors. [electronic resource]
Producer: 20210518Description: 110981 p. digitalISSN:- 1873-3344
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.